Chris Reef is an accomplished executive with extensive experience in leadership roles across various healthcare and operational sectors. Currently serving as an Operating Partner and Head of Operations at InTandem Capital Partners and as CEO of Vivo Infusion, Chris also contributes as a board member for both HouseWorks LLC and Adams Clinical. Previously, Chris held the position of CEO and Executive Chairman at Westlake Dimex, which was acquired by Westlake Chemical, and served as Executive Chairman at Sunbelt Transformer, acquired by Trilantic North America. Other significant roles include investor and advisor at Covenant Surgical Partners, CEO of Meritain Health, and founder of US Healthcare Holdings. Chris began the professional journey as a Healthcare Financial Associate at Medimetrix Consulting. Academic credentials include a Bachelor of Arts in Economics Management and Accounting from Ohio Wesleyan University and further education from The Wharton School.